Crossmark

A case report on the long-term survival of a patient with HER2-positive metastatic gastric adenocarcinoma and a short review of the current literature

Crossref DOI link: https://doi.org/10.1007/s12254-020-00649-2

Published Online: 2020-09-30

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Puhr, Hannah Christina

Ilhan-Mutlu, Aysegül https://orcid.org/0000-0001-8291-0873
Funding

Funding for this research was provided by:

Medical University of Vienna
License Information

Text and Data Mining valid from 2020-09-30

Version of Record valid from 2020-09-30
More Information

Article History

Received: 5 August 2020

Accepted: 1 September 2020

First Online: 30 September 2020

Conflict of interest

: H.C. Puhr has received travel support from Eli Lilly, MSD, Novartis, Pfizer and Roche. A. Ilhan-Mutlu participated in advisory boards from MSD and Servier, received lecture honoraria from Eli Lilly and Servier, is the local PI for clinical trials sponsored by BMS and Astellas.

Document is current

Any future updates will be listed below